Navigation Links
LeMaitre Vascular to Participate in 28th Annual Cowen and Company Health Care Conference
Date:3/11/2008

BURLINGTON, Mass., March 11 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, is scheduled to participate in the 28th Annual Cowen and Company Health Care Conference on Tuesday, March 18, 2008, in Boston.

George W. LeMaitre, Chairman and Chief Executive Officer, and David B. Roberts, President, will provide an update on the company at 10:15 am Eastern Time.

A live audio webcast of the presentation will be available via the Internet at http://ir.lemaitre.com and will be available for replay for approximately three months.

About LeMaitre Vascular

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease. The Company's principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com.


'/>"/>
SOURCE LeMaitre Vascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer
2. LeMaitre Vascular Appoints Russell D. Hays to Its Board of Directors
3. BioVascular, Inc. Expands Executive Team
4. HealthAware Introduces Its VascularAware Cardiovascular Disease Module
5. Topspin Medical Announces First Commercial Installation of the Cathamaran(TM) Intravascular MRI System
6. Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access
7. Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair
8. The Wisconsin Heart Hospital Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
9. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
10. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
11. VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... Executive ... 2017 in its continued commitment to the advancement of the clinical trials segment. ... issues related to clinical trial planning and management. , As executive talent ...
(Date:1/18/2017)... ... January 18, 2017 , ... Whitehouse Labs has ... Albany Molecular Research, Inc. (AMRI), the scientific staff dedicated to Extractables / Leachables ... for further growth in 2017. Extractable & Leachable evaluations have become increasingly more ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... paralysis, today announced that it has submitted a 510(k) to the FDA, requesting ... utilize MYOLYN’s patent-pending functional electrical stimulation (FES) technology. , The submission marks ...
(Date:1/18/2017)... PA (PRWEB) , ... January 18, 2017 , ... ... operations again at the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency ... engaging panel discussions to examine vital clinical research issues such as trial performance ...
Breaking Biology Technology:
(Date:12/20/2016)... LONDON , Dec. 20, 2016 ... car sharing, rental and leasing is stoking significant ... of radio frequency technology, Bluetooth low energy (BLE), ... emerge as the next wave of wireless technologies ... vehicle access system to advanced access systems opens ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... , Dec 16, 2016 Research and ... System Market - Global Forecast to 2021" report to their ... The ... to grow at a CAGR of 14.06% from 2016 to 2021. ... and is projected to reach 854.8 Million by 2021. The growth ...
Breaking Biology News(10 mins):